Literature DB >> 12688329

Idiopathic myelofibrosis associated with classic polyarteritis nodosa.

Mireia Camós1, Eduardo Arellano-Rodrigo, Deborah Abelló, Ana Muntañola, Ana Ferrer, Josep Maria Grau, Francisco Cervantes.   

Abstract

A woman with scleroderma and classic polyarteritis nodosa (PAN) who developed idiopathic myelofibrosis (IM) is reported. The patient presented with a one-year history of weakness, polyarthritis, Raynaud phenomenon, dry cough, and epigastralgia. The diagnosis of scleroderma with visceral involvement was made and treatment with prednisone subsequently started, with good clinical response. Six years later, fever, weight loss, livedo reticularis, and dysesthesias developed. Electromyographic studies were consistent with sensory neuropathy and a sural nerve biopsy yielded the diagnosis of PAN. The patient received cyclophosphamide plus prednisone with a favorable response, but 11 years later she was admitted because of weakness, constitutional symptoms, and abdominal pain due to spleen infarcts. Marked anemia, with aniso-poikilocytosis, tear-drop cells, immature myeloid precursors in the peripheral blood, and an increased serum LDH, was observed and the diagnosis of IM established by bone marrow biopsy. This case represents a new association between IM and an autoimmune disease and supports the hypothesis of an immune basis of IM in some patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12688329     DOI: 10.1080/1042819021000046849

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

Review 1.  Polyarteritis nodosa presenting as pancytopenia: case report and review of the literature.

Authors:  Leslie R Harrold; Nancy Y N Liu
Journal:  Rheumatol Int       Date:  2008-03-27       Impact factor: 2.631

Review 2.  An immune dysregulation in MPN.

Authors:  Giovanni Barosi
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

3.  Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy.

Authors:  Marianna Colagrande; Mauro Di Ianni; Gino Coletti; Ketty Peris; Maria Concetta Fargnoli; Lorenzo Moretti; Mario Lapecorella; Antonio Tabilio
Journal:  Int J Hematol       Date:  2008-12-04       Impact factor: 2.490

4.  Dermatomyositis Associated with Myelofibrosis following Polycythemia Vera.

Authors:  Naomi Fei; Sarah Sofka
Journal:  Case Rep Hematol       Date:  2017-06-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.